Key Takeaway: Proper preparation is the most effective way to eliminate injection stinging
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly for the treatment of type 2 diabetes and obesity
American Society of Anesthesiologists+1 In late 20242025 , multi-specialty guidance and larger studies began to suggest that most patients can safely continue GLP-1 medications , especially if they are stable on a long-term dose
Or call (800) 818-1779 Tested and approved Your prescription will be delivered directly from state-licensed and NABP multi-state regulated pharmacies
Feb 25, 2026 Some people find their tirzepatide provider on the first try
Both medications are changing the landscape of medical weight loss, and the right choice depends on your personal health goals, tolerance to side effects, and affordability